There is no current diagnosis of Type I diabetes, diabetic ketoacidosis, or pancreatitis
NSAIDs should be used cautiously and for the shortest duration necessary, particularly in patients with cardiovascular risk factors, kidney disease, or gastrointestinal conditions
Nothing in this timeline changes the core regulatory status today
The tesamorelin + ipamorelin blend half life we've discussed throughout this piece applies exclusively to subcutaneous or intravenous administration of intact, lyophilised, reconstituted peptides synthesized under GMP conditions with verified amino acid sequencing
Both oral and injectable forms are reportedly moving into phase 3 studies
Both are designed for patient self-administration and specifically engineered for subcutaneous delivery